GlassScriptPhysician profile
Micki N Ly
NPI 1346299435
$2,588.59
in general payments reported to CMS, 2019-2025
21 companies · $829 in 2025
The $829 reported for 2025 was more than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $43.21 · 2021: $232 · 2022: $136 · 2023: $496 · 2024: $447 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,762 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.40 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,094.66 | 2019-2025 | |
| Galderma Laboratories, L.P. | $302.95 | 2024-2025 | Nemluvio |
| Celgene Corporation | $171.18 | 2019 | |
| Genzyme Corporation | $137.36 | 2024-2025 | |
| Genentech USA, INC. | $115.47 | 2021-2025 | Xolair |
| Amgen INC. | $110.74 | 2021 | |
| Leo Pharma INC. | $105.77 | 2021-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $104.70 | 2021-2025 | Dupixent |
| Janssen Biotech, INC. | $79.81 | 2021-2025 | Simponi, Simponi Aria, Stelara |
| Pfizer INC. | $67.02 | 2022-2023 | |
| Organon LLC | $53.68 | 2025 | Vtama |
| Incyte Corporation | $49.79 | 2022-2023 | Opzelura |
| Sun Pharmaceutical Industries INC. | $48.53 | 2020-2025 | |
| Merz North America, INC. | $31.17 | 2019-2021 | |
| Biofrontera INC. | $23.12 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.45 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 2023 | Sotyktu |
| Organogenesis INC. | $15.78 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.31 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.10 | 2025 | |
| Nabriva Therapeutics, Plc | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micki Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.